Friday, December 05, 2025 | 03:01 PM ISTहिंदी में पढें
Business Standard
Notification Icon
userprofile IconSearch

Split CMD position: Medicine without ailment?

Appointment of a lead independent director might be a better option than mandating separation of the positions of chairperson and MD/CEO

Image
premium

Asish K Bhattacharyya
The Security and Exchange Board of India (Sebi) has deferred the date by which the top 500-listed companies are required to comply with the regulation to separate the roles of chairperson and managing director (MD)/chief executive officer (CEO) from April 1, 2020, to April 1, 2022. The Sebi regulation requires that the non-executive chairperson and the CEO should not be related according to the definition of a relative in the Companies Act, 2013. It is explained that Sebi has taken the decision to defer the applicability of the regulation in view of the demand from companies and to keep the
Disclaimer: These are personal views of the writer. They do not necessarily reflect the opinion of www.business-standard.com or the Business Standard newspaper